News Oncoinvent ASA

Equities

ONCIN

NO0013711713

Biotechnology & Medical Research

Real-time Oslo Bors Other stock markets 04:13:39 2026-04-16 am EDT			5-day change	1st Jan Change
48.30 ^NOK	-3.40%		+5.00%	-1.63%

Mar. 19	Oncoinvent Secures New Patent for Radspherin in China	MT
Mar. 19	Oncoinvent secures new patent expanding protection for Radspherin	RE

All News

Mar. 19	Oncoinvent Secures New Patent for Radspherin in China	MT
Mar. 19	Oncoinvent secures new patent expanding protection for Radspherin	RE
Mar. 19	Oncoinvent secures new patent expanding protection for Radspherin[®]	AQ
Mar. 19	Oncoinvent Secures New Patent Expanding Protection for Radspherin	CI
Mar. 11	Oncoinvent ASA: Grant of share options to the CEO	AQ
Feb. 26	Oncoinvent : Second half of 2025 report and presentation Presentation	PU
Feb. 26	Oncoinvent ASA: Second half 2025 results	AQ
Feb. 17	Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin[®] at ESGO 2026	AQ
Feb. 17	Oncoinvent to Present Positive 24-Month Follow-Up Data from Phase 1 Ovarian Cancer Study of Radspherin at ESGO 2026	CI
Feb. 16	Oncoinvent ASA, Announces webcast presentation of second half 2025 results on Thursday 26 February 2026	AQ
Feb. 16	Oncoinvent ASA: Announces webcast presentation of second half 2025 results on Thursday 26 February 2026	AQ
Feb. 03	Oncoinvent : Latest non-confidential presentation Presentation	PU
Jan. 29	Oncoinvent Announces Four Additional Sites Open for Recruitment in Oncoinvent's Phase 2 Trial	CI
Jan. 29	Four additional sites open for recruitment in Oncoinvent's Phase 2 trial	AQ
Jan. 20	Oncoinvent ASA: Registration of reverse share split	AQ
Jan. 19	Oncoinvent ASA: Ex. reverse share split and change of ISIN today	AQ
Jan. 15	Oncoinvent ASA, Key information relating to the reverse share split and Change of ISIN	AQ
Jan. 15	Oncoinvent ASA - New share capital registered	AQ
Jan. 14	Biotechnology Company Oncoinvent Outlines Reverse Share Split Plan	MT
Jan. 14	Oncoinvent ASA: Key information relating to the reverse share split and change of ISIN	AQ
Jan. 14	Oncoinvent ASA, Grant of share options to new CFO	AQ
Jan. 13	Oncoinvent ASA Announces Appointment of Ramzi Amri as CEO, Effective January 2026	CI
Jan. 13	Oncoinvent ASA: Grant of share options to new CFO	AQ
Jan. 08	Oncoinvent's shares to be consolidated in ratio of 100:1	RE
Dec. 22	Oncoinvent ASA: Grant of share options – mandatory notification of trade	PU